Call for Expression of Interest: Sub-Implementing Partners (Sub-IPs)Life-saving Facility and Community-based Service Delivery Support for Tuberculosis (FCSDS)

Background

Indonesia continues to carry one of the highest tuberculosis (TB) burdens globally, ranking second only to India. According to the World Health Organisation, the country experiences an estimated 1.08 million TB cases and approximately 126,100 TB-related deaths annually. While these figures reflect a persistent public health challenge, they also highlight the scale of the opportunity to make an impact through targeted, high-quality TB interventions.

In recent years, Indonesia has made notable progress in detecting TB cases. In 2024, the National Tuberculosis Program (NTP) achieved a TB case notification rate of 79%, with 856,420 cases detected out of an estimated 1.08 million. Case detection efforts have continued into 2025, with 753,065 TB cases notified as of 23 November 2025. Despite these gains, national TB case detection has plateaued since 2024 and is expected to remain at similar levels in 2025. This trend indicates diminishing returns from existing strategies, suggesting that further improvements in case detection will require a shift in approach rather than continued scale-up of current models.

Drug-resistant tuberculosis (DR/MDR-TB) remains a critical and unresolved challenge within Indonesia’s TB elimination efforts. In 2024, of an estimated 26,000 individuals who developed rifampicin-resistant TB (RR/MDR-TB), only 10,646 (41%) were diagnosed and notified. Among those notified, 8,833 (83%) initiated treatment. This pattern persists in 2025, with approximately 80% of diagnosed DR-TB patients enrolling in treatment. However, treatment outcomes remain suboptimal: the most recent DR-TB cohort (2022) reported a treatment success rate of only 59%, a figure that has remained unchanged as of November 2025. Structural constraints continue to limit access to care, as DR-TB services are concentrated in only 530 referral hospitals nationwide, posing significant geographic and financial barriers for patients. 

On the prevention side, tuberculosis preventive therapy (TPT) has demonstrated promising progress but remains underutilised. Over the past three years, the number of household contacts initiated on TPT has increased substantially, and treatment completion rates have improved dramatically—from 13% in the 2016 cohort to 73% in 2023. While these achievements demonstrate the feasibility of scaling preventive interventions, overall TPT coverage remains below national targets, indicating the need for further expansion and stronger integration with community-based service delivery.

Persistent gaps in TB case finding and reporting further undermine national TB control efforts. An estimated 93,000 TB cases—approximately 15.6% of total estimated incidence—go unreported annually. The majority of these missed notifications originate from private healthcare providers, reflecting ongoing challenges in Public–Private Mix (PPM) engagement and reporting. Even more concerning is the scale of underdiagnosis. Based on Indonesia’s second national TB inventory study, an estimated 142,000 individuals with TB are never diagnosed each year. Although underdiagnosis has declined modestly from 18% in 2017 to 14% in 2023, it still accounts for roughly half of the gap between estimated incidence and notified cases.

For many years, Indonesia’s TB response has benefited from substantial international support, including from the United States Agency for International Development (USAID), which through initiatives such as USAID BEBAS TB, USAID MENTARI TB, and USAID PREVENT TB supported critical functions including intensified and community-based TB case finding, strengthening of DR-TB service delivery and clinical capacity, and expansion of tuberculosis preventive treatment (TPT). The cessation of USAID’s TB program funding has created significant gaps in the continuation of these life-saving functions, particularly in high-burden and resource-constrained settings, posing risks to the continuity, quality, and equity of TB services. The FCSDS project is designed to stabilise and sustain these essential services by maintaining integrated case finding, strengthening DR-TB care and quality improvement mechanisms, reinforcing patient support and safety, and ensuring continued linkage to treatment and prevention in priority areas.

In response to this critical transition, the Life-saving Facility and Community-based Service Delivery Support for Tuberculosis (FCSDS) Project was designed as a targeted, adaptive intervention to safeguard essential TB services. At present, FCSDS is being implemented in four high-burden districts in West Java Province, with a primary focus on intensified TB case-finding through strengthened facility- and community-based approaches. This initial implementation serves as a proof of concept, demonstrating the feasibility and immediate value of focused, life-saving interventions in maintaining access to TB services during periods of funding uncertainty.

However, the epidemiology of TB in Indonesia necessitates a broader and more strategic response. Districts and municipalities in West Java and East Java together contribute approximately 30% of the national TB burden, making these regions decisive for achieving national TB targets. Limiting FCSDS to a small number of districts risks constraining its overall impact and leaving critical service gaps in other high-burden areas.

Moreover, a singular focus on case detection is insufficient to address Indonesia’s most pressing TB challenges. The persistent burden of DR-TB—characterised by low detection rates, delayed treatment initiation, poor treatment outcomes, and limited access to specialised services—demands an expanded and more comprehensive approach. Addressing DR-TB effectively requires integrated interventions that span early detection of drug resistance, timely referral and treatment initiation, patient-centred adherence support, and continuity of care across facility and community settings.

The proposed expansion of FCSDS, therefore, aims to expand geographic coverage to additional high-burden districts and municipalities that collectively account for a substantial proportion of Indonesia’s TB burden, while simultaneously broadening the scope of intervention. The expanded FCSDS model will move beyond intensified case finding alone to explicitly address key DR-TB bottlenecks, ensuring that patients are not only identified, but also successfully initiated on and retained in appropriate treatment.

The proposed expansion of FCSDS responds to clear evidence that existing TB strategies in Indonesia are reaching their limits. While intensified case finding and diagnostic scale-up have driven substantial gains in recent years, the plateauing of TB notifications since 2024 indicates diminishing returns from further expansion of the same approaches. Current models remain heavily focused on identification of cases, but are less effective in addressing downstream bottlenecks—particularly weak linkage to treatment, fragmented follow-up, and inconsistent quality of care—most visibly reflected in persistent losses across the DR-TB cascade.

The expanded FCSDS model introduces a qualitatively different approach by shifting from case finding as an endpoint to end-to-end cascade performance, with explicit emphasis on quality, continuity, and patient safety across both TB and DR-TB services. Beyond expanding geographic coverage, FCSDS integrates systematic screening with strengthened linkage to treatment, active drug safety monitoring, patient-centred support, and a structured quality improvement framework comprising MICA, mini-cohort reviews, clinical audit, and tiered clinical mentoring. These mechanisms create continuous feedback loops that translate detection gains into timely treatment initiation, sustained retention in care, and improved outcomes—particularly for DR-TB patients, where quality gaps have the greatest consequences.

Implementation of FCSDS is led by Stop TB Partnership Indonesia in close collaboration with government health services, civil society organisations, and community actors. Through this integrated, facility- and community-based model, FCSDS moves beyond incremental scale-up of existing activities to reconfigure how TB and DR-TB services function in high-burden settings, preserving hard-won gains, closing critical service gaps, and accelerating progress toward Indonesia's national TB elimination goals.

About STPI

Stop TB Partnership Indonesia (STPI), formally known as Yayasan Kemitraan Tuberculosis Indonesia, has been at the forefront of civil society efforts to accelerate TB elimination in Indonesia since 2018. Over the years, STPI has established itself as a key partner to the Government of Indonesia, bringing together communities, civil society, and stakeholders to strengthen the national TB response. Drawing on its extensive experience, reach, and technical expertise, STPI has earned the trust of partners as a driving force in Indonesia’s TB response.

The Opportunity

The FCSDS project is implemented by STPI through a decentralised implementation structure that leverages local presence and partnerships to ensure effective coordination and delivery at the district and city levels. To facilitate implementation, STPI works in close collaboration with Sub-Implementing Partners (Sub-IPs), which are locally established organizations with existing networks, operational experience, and strong contextual understanding in each of the 30 districts and cities. This approach enables timely decision-making, strengthens local ownership, and ensures that interventions are responsive to local health system dynamics.

We are seeking Sub-Implementing Partners (Sub-IPs) in 30 districts and cities across West Java and East Java Provinces, responsible for day-to-day coordination, field-level implementation, and engagement with local stakeholders, reporting to the Case Finding (CF) Lead and Drug-Resistant TB (DR-TB) Lead.

Objectives Targets Expected Result Scope of Work, Job Descriptions, and Responsibilities  Location	Ensure the implementation of FCSDS (Case Finding (CF) and DR-TB) interventions at the district/city levels is carried out in accordance with project timelines, expected results, and donor requirements. Facilitate effective coordination and collaboration with local stakeholders at the district/city levels related to project intervention. Promote efficiency and effectiveness in meeting human resource needs and managing project administrative requirements at the district and city levels. Local/national non-government organisations with demonstrated experience in implementing and managing TB interventions using patient-centred and community-based approaches. Sub-Implementing Partners are established across 2 Provinces (East Java and West Java), 30 districts and cities, operating under formal partnership agreements with clearly defined roles, responsibilities, and measurable implementation indicators. Details SOW in the attachment 2: (check the document below) Support the development of district/city-level monthly activity planning and budgets for CF and DR-TB interventions, ensuring alignment with project budget and workplan; Responsible for the day-to-day implementation of DR-TB interventions at the district/city level, including DR-TB diagnosis, treatment enrollment, treatment outcomes, and service quality improvement; Responsible for the day-to-day implementation of Case Finding (CF) interventions at the district/city level, including Active Case Finding (ACF), contact investigation, community outreach, TB Preventive Treatment (TPT) initiation and completion, enrollment of TB treatment, and treatment adherence support; Manage and supervise field teams implementing DR-TB and CF interventions at the district/city level; Manage financial and administrative aspects of project implementation, meeting both internal and external requirements; Coordinate and engage with local stakeholders to strengthen local ownership, address operational challenges, and ensure effective and high-quality implementation at the district/city level. Document intervention progress and analyse operational data to support project learning, adaptive management, and evidence-based decision-making; Coordinate closely with the FCSDS national team to receive day-to-day technical guidance, escalate operational constraints, and report implementation progress; Management of HR payroll in accordance with policies and guidelines issued by Stop TB Partnership Indonesia (STPI); management of activity-related funding in line with project standardisation; and management of supporting budgets in compliance with procedures and financial controls established by STPI. Each Sub-Implementing Partner will operate in 1 district/city across 30 districts/cities in West Java and East Java (Please do select your proposed district/city based on your organization's capacity) - see attachment 3 for the expected area of intervention.
Duration of Implementation	February- September 2026
Supervisor Team	A Sub-IP is responsible to the FCSDS national team with direct supervision from the DR TB Lead and Case Finding Lead, day-to-day coordination with the Technical Officer, and assistance from the Provincial Coordinator.
Qualification Team Compostion Attached Documents Needed Recruitment Timeline	Required qualifications: attachment 1 Each team will consist of 6 persons:1. District Coordinator (1 person)2. District Technical Officer (2 persons)3. District MEL Officer (2 Persons)4. District Finance and Admin Officer (1 person) Each Sub-Implementing Partner is required to submit an Expression of Interest  and supporting documents as follows:  Legal and administrative documents of the legal entity, including but not limited to: Notarial Deed/Amendment Deed (Akta Notaris/Akta Perubahan), Decree of the Ministry of Law and Human Rights (SK Kementerian Hukum dan HAM); Taxpayer Identification Number (NPWP); and a verifiable organizational address. Organisational profile, including: organization name, name of organizational head, email address, telephone number, organizational structure, organizational work programs, portfolio—particularly experience in TB programs—and legal status of the organization. Letter of reference from the District/City Health Office (optional but desirable). Standard Operating Procedures (SOPs) for organizational management, including program management, financial management, monitoring and evaluation (M&E), code of conduct, PSEAH, and other relevant policies. Curriculum vitae (CVs) of proposed personnel to implement the FCSDS project at the Sub-Implementing Partner (Sub-IP) level. These CVs represent the initial proposed personnel; any subsequent changes to personnel during the implementation period will be permitted, subject to notification and approval in accordance with project governance requirements. Statement of commitment letter confirming staff and institutional commitment to implement the FCSDS project as a Sub-IPs throughout the project period (February-September 2026) Open recruitment announcement: 20 January 2026  Administration completeness verification: 27 January 2026 Interview (online): 28 - 30 January 2026 Result of selection announcement: 2 February 2026 Contract agreement sign: 4 February 2026

Important Note on Recruitment Process: 

1. Sub-IP candidates are expected to submit the email of Expression of Interest with attachment of supporting documents via the following Google Form link: Application Form - Sub-Implementing Partners (Sub-IPs). The submission deadline will be on January 26th 2026.

2. Only shortlisted candidates will receive further communication, and those not selected for advancement will not be individually notified.

3. Stop TB Partnership Indonesia is an institution that opens equal opportunities for everyone. Applicants may not be discriminated against because of race, religion, gender, national origin, ethnicity, age, disability, political affiliation, sexual orientation, gender identity, skin colour, and/or marital status.

4. Stop TB Partnership accommodates applicants with disabilities, allowing them to participate in the application process. Please notify us in writing of any special needs at the time of application.

Attachement Document:

Attachment Qualifications and Scope Of Work.pdf

Unduh PDF • 167KB